Omada Health vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Omada Health is a virtual-first chronic care platform for diabetes, hypertension, and musculoskeletal conditions serving 2,000+ employer and health plan customers, with $170M 2024 revenue and a June 2025 Nasdaq IPO (OMDA).
About
Omada Health is a San Francisco-based digital health company founded in 2012 that offers virtual-first care programs for chronic conditions including prediabetes, Type 1 and Type 2 diabetes, hypertension, and musculoskeletal disorders. The platform combines human health coaches, licensed clinical practitioners, and connected devices—including cellular-enabled scales and continuous glucose monitors—with behavior science and clinical protocols to deliver personalized, data-driven care at scale. Omada describes its approach as "Compassionate Intelligence," integrating human relationships with AI-driven personalization.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Omada Health vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.